Suppr超能文献

异基因干细胞移植受者中细小病毒B19血浆DNA血症的动态变化

Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.

作者信息

Albert Eliseo, Solano Carlos, Pascual Tania, Torres Ignacio, Macera Lisa, Focosi Daniele, Maggi Fabrizio, Giménez Estela, Amat Paula, Navarro David

机构信息

Microbiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.

Hematology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.

出版信息

J Clin Virol. 2017 Sep;94:22-28. doi: 10.1016/j.jcv.2017.07.001. Epub 2017 Jul 8.

Abstract

BACKGROUND

Torque Teno virus (TTV) plasma DNA load directly correlate with the level of immunosuppresion in different clinical settings. It is uncertain whether this may be the case in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT).

OBJECTIVES

We characterized the dynamics of TTV DNAemia in patients undergoing T-cell replete allo-SCT.

STUDY DESIGN

Retrospective single-center observational study including 72 allo-HSCT patients. Plasma TTV DNA loads were quantified before initiating the conditioning regimen and at different time-points after transplant by real-time PCR. White blood cells (WBC) and absolute lymphocyte counts (ALC) were measured by flow cytometry.

RESULTS

A dramatic drop in plasma TTV DNA load was observed shortly after conditioning. The TTV DNA load increased steadily after engraftment reaching its peak at day +90 after transplant. The increase in TTV DNA load paralleled that of ALC, and was of greater magnitude in patients who developed severe (grades II-IV) acute graft vs. host disease.

CONCLUSION

Repopulation of lymphocytes early after allo-HSCT correlates with an increase of plasma TTV DNA load. Prospective studies are nevertheless needed to determine whether the kinetics of TTV DNAemia may allow inference of the degree of overall immunocompetence in these patients.

摘要

背景

在不同临床环境中,细小病毒B19(TTV)血浆DNA载量与免疫抑制水平直接相关。在异基因造血干细胞移植受者(allo-HSCT)中是否也是如此尚不确定。

目的

我们对接受T细胞充足的异基因造血干细胞移植(allo-SCT)患者的TTV DNA血症动态进行了特征描述。

研究设计

一项回顾性单中心观察性研究,纳入72例allo-HSCT患者。在开始预处理方案前以及移植后的不同时间点,通过实时聚合酶链反应(PCR)对血浆TTV DNA载量进行定量。通过流式细胞术检测白细胞(WBC)和绝对淋巴细胞计数(ALC)。

结果

预处理后不久,血浆TTV DNA载量急剧下降。移植后植入后TTV DNA载量稳步上升,在移植后第90天达到峰值。TTV DNA载量的增加与ALC的增加平行,在发生严重(II-IV级)急性移植物抗宿主病的患者中增幅更大。

结论

allo-HSCT后早期淋巴细胞的重新增殖与血浆TTV DNA载量的增加相关。然而,仍需要进行前瞻性研究以确定TTV DNA血症的动力学是否可用于推断这些患者的总体免疫能力程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验